Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.
作者信息
Shelley M D, Fish R G, Adams M, Kerby I
出版信息
Br J Cancer. 1985 Aug;52(2):275-7. doi: 10.1038/bjc.1985.188.
Abstract
摘要
相似文献
1
Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.卵巢癌患者的囊液-铂动力学：与顺二氯二氨铂（II）体外敏感性测试的相关性
Br J Cancer. 1985 Aug;52(2):275-7. doi: 10.1038/bjc.1985.188.
2
Platinum kinetics in patients treated with cis-dichlorodiammine platinum (II).顺二氯二氨铂（II）治疗患者的铂动力学
Ther Drug Monit. 1982;4(3):293-6. doi: 10.1097/00007691-198208000-00007.
3
4
Accumulation of platinum in the intervertebral discs and vertebrae of ovarian tumor-bearing patients treated with cisplatin.顺铂治疗的卵巢肿瘤患者椎间盘和椎体中铂的蓄积。
Biol Trace Elem Res. 1994 Sep;42(3):253-7. doi: 10.1007/BF02911522.
5
Breast metastasis of ovarian cancer during cis-platinum therapy. A case report and review of the literature.顺铂治疗期间卵巢癌发生乳腺转移。一例病例报告及文献复习。
Eur J Gynaecol Oncol. 1985;6(1):62-5.
6
Kinetics of cis-dichlorodiammineplatinum.
Clin Pharmacol Ther. 1979 Mar;25(3):351-7. doi: 10.1002/cpt1979253351.
7
Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro.在体外对数生长期的两种卵巢肿瘤细胞系中，甘氨脱氧胸苷对铂-DNA加合物形成和去除的影响不显著。
Carcinogenesis. 1991 Mar;12(3):525-8. doi: 10.1093/carcin/12.3.525.
8
Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary.孕期铂类化疗用于卵巢浆液性囊腺癌
Gynecol Oncol. 1993 Apr;49(1):92-4. doi: 10.1006/gyno.1993.1092.
9
The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy.在使用顺铂或卡铂进行癌症化疗后，铂在人体组织中的长期留存情况。
Eur J Cancer. 1992;28A(8-9):1358-61. doi: 10.1016/0959-8049(92)90519-8.
10
Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells.
Oncology. 1992;49(3):173-9. doi: 10.1159/000227034.
本文引用的文献
1
Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.采用人肿瘤干细胞检测法对抗癌药物进行的药理学研究。
Cancer Chemother Pharmacol. 1981;6(3):253-64. doi: 10.1007/BF00256978.
2
Single-agent cis-platinum therapy for advanced ovarian cancer.顺铂单药治疗晚期卵巢癌。
Obstet Gynecol. 1981 Oct;58(4):487-96.
3
In vitro methods to predict for patient response to chemotherapy.预测患者化疗反应的体外方法。
Adv Pharmacol Chemother. 1980;17:133-56. doi: 10.1016/s1054-3589(08)60009-5.
4
In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.人卵巢肿瘤对化疗药物的体外敏感性
Br J Cancer. 1981 Aug;44(2):189-200. doi: 10.1038/bjc.1981.170.
5
Total body clearance and platinum accumulation in patients treated with cis-dichlorodiammine platinum (II).接受顺二氯二氨铂（II）治疗的患者的全身清除率和铂蓄积情况。
Ther Drug Monit. 1984;6(2):251-2. doi: 10.1097/00007691-198406000-00021.
6
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.短期输注顺铂后游离铂和总铂物种的药代动力学。
Cancer Treat Rep. 1984 Mar;68(3):505-13.
7
Effect of mannitol and plasma on the cytotoxicity of cisplatin.甘露醇和血浆对顺铂细胞毒性的影响。
Eur J Cancer Clin Oncol. 1983 Apr;19(4):515-8. doi: 10.1016/0277-5379(83)90115-3.
8
"Send this patient's tumor for culture and sensitivity".将该患者的肿瘤送去做培养及药敏试验。
N Engl J Med. 1983 Jan 20;308(3):154-5. doi: 10.1056/NEJM198301203080310.
Zotero 插件